TY - JOUR AU - Varol, C. PY - 2015 DA - 2015// TI - Macrophages: development and tissue specialization JO - Annu Rev Immunol. VL - 33 UR - https://doi.org/10.1146/annurev-immunol-032414-112220 DO - 10.1146/annurev-immunol-032414-112220 ID - Varol2015 ER - TY - JOUR AU - Martinez, F. O. PY - 2008 DA - 2008// TI - Macrophage activation and polarization JO - Front Biosci VL - 13 UR - https://doi.org/10.2741/2692 DO - 10.2741/2692 ID - Martinez2008 ER - TY - JOUR AU - Martinez, F. O. PY - 2009 DA - 2009// TI - Alternative activation of macrophages: an immunologic functional perspective JO - Annu Rev Immunol VL - 27 UR - https://doi.org/10.1146/annurev.immunol.021908.132532 DO - 10.1146/annurev.immunol.021908.132532 ID - Martinez2009 ER - TY - JOUR AU - Mills, C. D. PY - 2000 DA - 2000// TI - M-1/M-2 macrophages and the Th1/Th2 paradigm JO - J Immunol VL - 164 UR - https://doi.org/10.4049/jimmunol.164.12.6166 DO - 10.4049/jimmunol.164.12.6166 ID - Mills2000 ER - TY - JOUR AU - Artyomov, M. N. PY - 2016 DA - 2016// TI - Integrating immunometabolism and macrophage diversity JO - Semin Immunol VL - 28 UR - https://doi.org/10.1016/j.smim.2016.10.004 DO - 10.1016/j.smim.2016.10.004 ID - Artyomov2016 ER - TY - JOUR AU - Lachmandas, E. PY - 2016 DA - 2016// TI - Microbial stimulation of different Toll-like receptor signalling pathways induces diverse metabolic programmes in human monocytes JO - Nat Microbiol VL - 2 UR - https://doi.org/10.1038/nmicrobiol.2016.246 DO - 10.1038/nmicrobiol.2016.246 ID - Lachmandas2016 ER - TY - JOUR AU - Weinberg, J. B. PY - 1995 DA - 1995// TI - Human mononuclear phagocyte inducible nitric oxide synthase (iNOS): analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages JO - Blood VL - 86 UR - https://doi.org/10.1182/blood.V86.3.1184.1184 DO - 10.1182/blood.V86.3.1184.1184 ID - Weinberg1995 ER - TY - JOUR AU - Schneemann, M. AU - Schoedon, G. PY - 2002 DA - 2002// TI - Species differences in macrophage NO production are important JO - Nat Immunol VL - 3 UR - https://doi.org/10.1038/ni0202-102a DO - 10.1038/ni0202-102a ID - Schneemann2002 ER - TY - JOUR AU - Rath, M. PY - 2014 DA - 2014// TI - Metabolism via Arginase or Nitric Oxide Synthase: Two Competing Arginine Pathways in Macrophages JO - Front Immunol VL - 5 UR - https://doi.org/10.3389/fimmu.2014.00532 DO - 10.3389/fimmu.2014.00532 ID - Rath2014 ER - TY - JOUR AU - MacMicking, J. PY - 1997 DA - 1997// TI - Nitric oxide and macrophage function JO - Annu Rev Immunol VL - 15 UR - https://doi.org/10.1146/annurev.immunol.15.1.323 DO - 10.1146/annurev.immunol.15.1.323 ID - MacMicking1997 ER - TY - JOUR AU - Bossche, J. PY - 2016 DA - 2016// TI - Mitochondrial Dysfunction Prevents Repolarization of Inflammatory Macrophages JO - Cell Rep VL - 17 UR - https://doi.org/10.1016/j.celrep.2016.09.008 DO - 10.1016/j.celrep.2016.09.008 ID - Bossche2016 ER - TY - JOUR AU - Palmieri, E. M. PY - 2020 DA - 2020// TI - Nitric oxide orchestrates metabolic rewiring in M1 macrophages by targeting aconitase 2 and pyruvate dehydrogenase JO - Nat Commun VL - 11 UR - https://doi.org/10.1038/s41467-020-14433-7 DO - 10.1038/s41467-020-14433-7 ID - Palmieri2020 ER - TY - JOUR AU - Connelly, L. PY - 2001 DA - 2001// TI - Biphasic regulation of NF-kappa B activity underlies the pro- and anti-inflammatory actions of nitric oxide JO - J Immunol VL - 166 UR - https://doi.org/10.4049/jimmunol.166.6.3873 DO - 10.4049/jimmunol.166.6.3873 ID - Connelly2001 ER - TY - JOUR AU - Qualls, J. E. PY - 2012 DA - 2012// TI - Sustained generation of nitric oxide and control of mycobacterial infection requires argininosuccinate synthase 1 JO - Cell Host Microbe VL - 12 UR - https://doi.org/10.1016/j.chom.2012.07.012 DO - 10.1016/j.chom.2012.07.012 ID - Qualls2012 ER - TY - STD TI - Lunt SY, Vander Heiden MG. Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu Rev Cell Dev Biol. ​2011;27:441–464. ID - ref15 ER - TY - JOUR AU - Warburg, O. PY - 1927 DA - 1927// TI - The metabolism of tumors in the body JO - J Gen Physiol VL - 8 UR - https://doi.org/10.1085/jgp.8.6.519 DO - 10.1085/jgp.8.6.519 ID - Warburg1927 ER - TY - JOUR AU - Hard, G. C. PY - 1970 DA - 1970// TI - Some biochemical aspects of the immune macrophage JO - Br J Exp Pathol. VL - 51 ID - Hard1970 ER - TY - JOUR AU - Newsholme, P. PY - 1987 DA - 1987// TI - Rates of utilization and fates of glucose, glutamine, pyruvate, fatty acids and ketone bodies by mouse macrophages JO - Biochem J VL - 242 UR - https://doi.org/10.1042/bj2420631 DO - 10.1042/bj2420631 ID - Newsholme1987 ER - TY - JOUR AU - Newsholme, P. PY - 1986 DA - 1986// TI - Metabolism of glucose, glutamine, long-chain fatty acids and ketone bodies by murine macrophages JO - Biochem J. VL - 239 UR - https://doi.org/10.1042/bj2390121 DO - 10.1042/bj2390121 ID - Newsholme1986 ER - TY - JOUR AU - Rodriguez-Prados, J. C. PY - 2010 DA - 2010// TI - Substrate fate in activated macrophages: a comparison between innate, classic, and alternative activation JO - J Immunol VL - 185 UR - https://doi.org/10.4049/jimmunol.0901698 DO - 10.4049/jimmunol.0901698 ID - Rodriguez-Prados2010 ER - TY - JOUR AU - Bossche, J. PY - 2015 DA - 2015// TI - Metabolic characterization of polarized M1 and M2 bone marrow-derived macrophages using real-time extracellular flux analysis JO - J Vis Exp. VL - 105 ID - Bossche2015 ER - TY - JOUR AU - Freemerman, A. J. PY - 2014 DA - 2014// TI - Metabolic reprogramming of macrophages: glucose transporter 1 (GLUT1)-mediated glucose metabolism drives a proinflammatory phenotype JO - J Biol Chem. VL - 289 UR - https://doi.org/10.1074/jbc.M113.522037 DO - 10.1074/jbc.M113.522037 ID - Freemerman2014 ER - TY - JOUR AU - Pavlou, S. PY - 2017 DA - 2017// TI - Higher phagocytic activity of thioglycollate-elicited peritoneal macrophages is related to metabolic status of the cells JO - J inflamm (London, England). VL - 14 UR - https://doi.org/10.1186/s12950-017-0151-x DO - 10.1186/s12950-017-0151-x ID - Pavlou2017 ER - TY - STD TI - O’Neill LA. A guide to immunometabolism for immunologists. Nat Rev Immunol. 2016;16(9):553–65. ID - ref24 ER - TY - JOUR AU - Nagy, C. AU - Haschemi, A. PY - 2015 DA - 2015// TI - Time and Demand are Two Critical Dimensions of Immunometabolism: The Process of Macrophage Activation and the Pentose Phosphate Pathway JO - Front Immunol. VL - 6 ID - Nagy2015 ER - TY - JOUR AU - Wilson, J. E. PY - 2003 DA - 2003// TI - Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function JO - J Exp Biol. VL - 206 UR - https://doi.org/10.1242/jeb.00241 DO - 10.1242/jeb.00241 ID - Wilson2003 ER - TY - JOUR AU - Moon, J. S. PY - 2015 DA - 2015// TI - mTORC1-Induced HK1-Dependent Glycolysis Regulates NLRP3 Inflammasome Activation JO - Cell Rep. VL - 12 UR - https://doi.org/10.1016/j.celrep.2015.05.046 DO - 10.1016/j.celrep.2015.05.046 ID - Moon2015 ER - TY - JOUR AU - Wolf, A. J. PY - 2016 DA - 2016// TI - Hexokinase Is an Innate Immune Receptor for the Detection of Bacterial Peptidoglycan JO - Cell. VL - 166 UR - https://doi.org/10.1016/j.cell.2016.05.076 DO - 10.1016/j.cell.2016.05.076 ID - Wolf2016 ER - TY - JOUR AU - Jiang, H. PY - 2016 DA - 2016// TI - PFKFB3-Driven Macrophage Glycolytic Metabolism Is a Crucial Component of Innate Antiviral Defense JO - J Immunol VL - 197 UR - https://doi.org/10.4049/jimmunol.1600474 DO - 10.4049/jimmunol.1600474 ID - Jiang2016 ER - TY - JOUR AU - Hackett, E. E. PY - 2020 DA - 2020// TI - Mycobacterium tuberculosis Limits Host Glycolysis and IL-1beta by Restriction of PFK-M via MicroRNA-21 JO - Cell Rep VL - 30 UR - https://doi.org/10.1016/j.celrep.2019.12.015 DO - 10.1016/j.celrep.2019.12.015 ID - Hackett2020 ER - TY - JOUR AU - Galvan-Pena, S. PY - 2019 DA - 2019// TI - Malonylation of GAPDH is an inflammatory signal in macrophages JO - Nat Commun VL - 10 UR - https://doi.org/10.1038/s41467-018-08187-6 DO - 10.1038/s41467-018-08187-6 ID - Galvan-Pena2019 ER - TY - JOUR AU - Palsson-McDermott, E. M. PY - 2015 DA - 2015// TI - Pyruvate kinase M2 regulates Hif-1alpha activity and IL-1beta induction and is a critical determinant of the warburg effect in LPS-activated macrophages JO - Cell Metab. VL - 21 UR - https://doi.org/10.1016/j.cmet.2014.12.005 DO - 10.1016/j.cmet.2014.12.005 ID - Palsson-McDermott2015 ER - TY - JOUR AU - Xie, M. PY - 2016 DA - 2016// TI - PKM2-dependent glycolysis promotes NLRP3 and AIM2 inflammasome activation JO - Nat Commun. VL - 7 UR - https://doi.org/10.1038/ncomms13280 DO - 10.1038/ncomms13280 ID - Xie2016 ER - TY - JOUR AU - Tan, Z. PY - 2015 DA - 2015// TI - Pyruvate dehydrogenase kinase 1 participates in macrophage polarization via regulating glucose metabolism JO - J Immunol. VL - 194 UR - https://doi.org/10.4049/jimmunol.1402469 DO - 10.4049/jimmunol.1402469 ID - Tan2015 ER - TY - JOUR AU - Semba, H. PY - 2016 DA - 2016// TI - HIF-1alpha-PDK1 axis-induced active glycolysis plays an essential role in macrophage migratory capacity JO - Nat Commun. VL - 7 UR - https://doi.org/10.1038/ncomms11635 DO - 10.1038/ncomms11635 ID - Semba2016 ER - TY - JOUR AU - Covarrubias, A. J. PY - 2016 DA - 2016// TI - Akt-mTORC1 signaling regulates Acly to integrate metabolic input to control of macrophage activation JO - Elife. VL - 5 UR - https://doi.org/10.7554/eLife.11612 DO - 10.7554/eLife.11612 ID - Covarrubias2016 ER - TY - JOUR AU - Huang, S. C. PY - 2016 DA - 2016// TI - Metabolic Reprogramming Mediated by the mTORC2-IRF4 Signaling Axis Is Essential for Macrophage Alternative Activation JO - Immunity. VL - 45 UR - https://doi.org/10.1016/j.immuni.2016.09.016 DO - 10.1016/j.immuni.2016.09.016 ID - Huang2016 ER - TY - JOUR AU - Wang, F. PY - 2018 DA - 2018// TI - Glycolytic Stimulation Is Not a Requirement for M2 Macrophage Differentiation JO - Cell Metab. VL - 28 UR - https://doi.org/10.1016/j.cmet.2018.08.012 DO - 10.1016/j.cmet.2018.08.012 ID - Wang2018 ER - TY - JOUR AU - Patra, K. C. AU - Hay, N. PY - 2014 DA - 2014// TI - The pentose phosphate pathway and cancer JO - Trends Biochem Sci. VL - 39 UR - https://doi.org/10.1016/j.tibs.2014.06.005 DO - 10.1016/j.tibs.2014.06.005 ID - Patra2014 ER - TY - JOUR AU - Jha, A. K. PY - 2015 DA - 2015// TI - Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization JO - Immunity. VL - 42 UR - https://doi.org/10.1016/j.immuni.2015.02.005 DO - 10.1016/j.immuni.2015.02.005 ID - Jha2015 ER - TY - JOUR AU - Haschemi, A. PY - 2012 DA - 2012// TI - The sedoheptulose kinase CARKL directs macrophage polarization through control of glucose metabolism JO - Cell Metab. VL - 15 UR - https://doi.org/10.1016/j.cmet.2012.04.023 DO - 10.1016/j.cmet.2012.04.023 ID - Haschemi2012 ER - TY - JOUR AU - Martínez-Reyes, I. AU - Chandel, N. S. PY - 2020 DA - 2020// TI - Mitochondrial TCA cycle metabolites control physiology and disease JO - Nat Commun. VL - 11 UR - https://doi.org/10.1038/s41467-019-13668-3 DO - 10.1038/s41467-019-13668-3 ID - Martínez-Reyes2020 ER - TY - JOUR AU - Lauterbach, M. A. PY - 2019 DA - 2019// TI - Toll-like Receptor Signaling Rewires Macrophage Metabolism and Promotes Histone Acetylation via ATP-Citrate Lyase JO - Immunity. VL - 51 UR - https://doi.org/10.1016/j.immuni.2019.11.009 DO - 10.1016/j.immuni.2019.11.009 ID - Lauterbach2019 ER - TY - JOUR AU - Infantino, V. PY - 2011 DA - 2011// TI - The mitochondrial citrate carrier: a new player in inflammation JO - Biochem J. VL - 438 UR - https://doi.org/10.1042/BJ20111275 DO - 10.1042/BJ20111275 ID - Infantino2011 ER - TY - JOUR AU - Infantino, V. PY - 2014 DA - 2014// TI - A key role of the mitochondrial citrate carrier (SLC25A1) in TNFalpha- and IFNgamma-triggered inflammation JO - Biochim Biophys Acta. VL - 1839 UR - https://doi.org/10.1016/j.bbagrm.2014.07.013 DO - 10.1016/j.bbagrm.2014.07.013 ID - Infantino2014 ER - TY - JOUR AU - Infantino, V. PY - 2013 DA - 2013// TI - ATP-citrate lyase is essential for macrophage inflammatory response JO - Biochem Biophys Res Commun. VL - 440 UR - https://doi.org/10.1016/j.bbrc.2013.09.037 DO - 10.1016/j.bbrc.2013.09.037 ID - Infantino2013 ER - TY - JOUR AU - Michelucci, A. PY - 2013 DA - 2013// TI - Immune-responsive gene 1 protein links metabolism to immunity by catalyzing itaconic acid production JO - Proc Natl Acad Sci U S A VL - 110 UR - https://doi.org/10.1073/pnas.1218599110 DO - 10.1073/pnas.1218599110 ID - Michelucci2013 ER - TY - JOUR AU - Lampropoulou, V. PY - 2016 DA - 2016// TI - Itaconate Links Inhibition of Succinate Dehydrogenase with Macrophage Metabolic Remodeling and Regulation of Inflammation JO - Cell Metab VL - 24 UR - https://doi.org/10.1016/j.cmet.2016.06.004 DO - 10.1016/j.cmet.2016.06.004 ID - Lampropoulou2016 ER - TY - JOUR AU - Mills, E. L. PY - 2018 DA - 2018// TI - Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1 JO - Nature VL - 556 UR - https://doi.org/10.1038/nature25986 DO - 10.1038/nature25986 ID - Mills2018 ER - TY - JOUR AU - Kobayashi, E. H. PY - 2016 DA - 2016// TI - Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription JO - Nat Commun. VL - 7 UR - https://doi.org/10.1038/ncomms11624 DO - 10.1038/ncomms11624 ID - Kobayashi2016 ER - TY - JOUR AU - Bambouskova, M. PY - 2018 DA - 2018// TI - Electrophilic properties of itaconate and derivatives regulate the IkappaBzeta-ATF3 inflammatory axis JO - Nature. VL - 556 UR - https://doi.org/10.1038/s41586-018-0052-z DO - 10.1038/s41586-018-0052-z ID - Bambouskova2018 ER - TY - JOUR AU - Liao, S. T. PY - 2019 DA - 2019// TI - 4-Octyl itaconate inhibits aerobic glycolysis by targeting GAPDH to exert anti-inflammatory effects JO - Nat Commun. VL - 10 UR - https://doi.org/10.1038/s41467-019-13078-5 DO - 10.1038/s41467-019-13078-5 ID - Liao2019 ER - TY - JOUR AU - Tannahill, G. M. PY - 2013 DA - 2013// TI - Succinate is an inflammatory signal that induces IL-1beta through HIF-1alpha JO - Nature. VL - 496 UR - https://doi.org/10.1038/nature11986 DO - 10.1038/nature11986 ID - Tannahill2013 ER - TY - JOUR AU - Palmieri, F. PY - 2004 DA - 2004// TI - The mitochondrial transporter family (SLC25): physiological and pathological implications JO - Pflugers Arch. VL - 447 UR - https://doi.org/10.1007/s00424-003-1099-7 DO - 10.1007/s00424-003-1099-7 ID - Palmieri2004 ER - TY - JOUR AU - Littlewood-Evans, A. PY - 2016 DA - 2016// TI - GPR91 senses extracellular succinate released from inflammatory macrophages and exacerbates rheumatoid arthritis JO - J Exp Med. VL - 213 UR - https://doi.org/10.1084/jem.20160061 DO - 10.1084/jem.20160061 ID - Littlewood-Evans2016 ER - TY - JOUR AU - Chouchani, E. T. PY - 2014 DA - 2014// TI - Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS JO - Nature. VL - 515 UR - https://doi.org/10.1038/nature13909 DO - 10.1038/nature13909 ID - Chouchani2014 ER - TY - JOUR AU - Röhrig, F. AU - Schulze, A. PY - 2016 DA - 2016// TI - The multifaceted roles of fatty acid synthesis in cancer JO - Nat Rev Cancer. VL - 16 UR - https://doi.org/10.1038/nrc.2016.89 DO - 10.1038/nrc.2016.89 ID - Röhrig2016 ER - TY - JOUR AU - Knottnerus, S. J. G. PY - 2018 DA - 2018// TI - Disorders of mitochondrial long-chain fatty acid oxidation and the carnitine shuttle JO - Rev Endocr Metab Disord. VL - 19 UR - https://doi.org/10.1007/s11154-018-9448-1 DO - 10.1007/s11154-018-9448-1 ID - Knottnerus2018 ER - TY - JOUR AU - Feingold, K. R. PY - 2012 DA - 2012// TI - Mechanisms of triglyceride accumulation in activated macrophages JO - J Leukoc Biol. VL - 92 UR - https://doi.org/10.1189/jlb.1111537 DO - 10.1189/jlb.1111537 ID - Feingold2012 ER - TY - JOUR AU - Im, S. S. PY - 2011 DA - 2011// TI - Linking lipid metabolism to the innate immune response in macrophages through sterol regulatory element binding protein-1a JO - Cell Metab. VL - 13 UR - https://doi.org/10.1016/j.cmet.2011.04.001 DO - 10.1016/j.cmet.2011.04.001 ID - Im2011 ER - TY - JOUR AU - Moon, J. S. PY - 2015 DA - 2015// TI - UCP2-induced fatty acid synthase promotes NLRP3 inflammasome activation during sepsis JO - J Clin Invest. VL - 125 UR - https://doi.org/10.1172/JCI78253 DO - 10.1172/JCI78253 ID - Moon2015 ER - TY - JOUR AU - Gianfrancesco, M. A. PY - 2019 DA - 2019// TI - Saturated fatty acids induce NLRP3 activation in human macrophages through K(+) efflux resulting from phospholipid saturation and Na, K-ATPase disruption JO - Biochim Biophys Acta Mol Cell Biol Lipids. VL - 1864 UR - https://doi.org/10.1016/j.bbalip.2019.04.001 DO - 10.1016/j.bbalip.2019.04.001 ID - Gianfrancesco2019 ER - TY - JOUR AU - Moon, J. S. PY - 2016 DA - 2016// TI - NOX4-dependent fatty acid oxidation promotes NLRP3 inflammasome activation in macrophages JO - Nat Med. VL - 22 UR - https://doi.org/10.1038/nm.4153 DO - 10.1038/nm.4153 ID - Moon2016 ER - TY - JOUR AU - Ecker, J. PY - 2010 DA - 2010// TI - Induction of fatty acid synthesis is a key requirement for phagocytic differentiation of human monocytes JO - Proc Natl Acad Sci U S A. VL - 107 UR - https://doi.org/10.1073/pnas.0912059107 DO - 10.1073/pnas.0912059107 ID - Ecker2010 ER - TY - JOUR AU - Vats, D. PY - 2006 DA - 2006// TI - Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation JO - Cell Metab. VL - 4 UR - https://doi.org/10.1016/j.cmet.2006.05.011 DO - 10.1016/j.cmet.2006.05.011 ID - Vats2006 ER - TY - JOUR AU - Huang, S. C. PY - 2014 DA - 2014// TI - Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages JO - Nat Immunol. VL - 15 UR - https://doi.org/10.1038/ni.2956 DO - 10.1038/ni.2956 ID - Huang2014 ER - TY - JOUR AU - Namgaladze, D. AU - Brune, B. PY - 2014 DA - 2014// TI - Fatty acid oxidation is dispensable for human macrophage IL-4-induced polarization JO - Biochim Biophys Acta. VL - 1841 UR - https://doi.org/10.1016/j.bbalip.2014.06.007 DO - 10.1016/j.bbalip.2014.06.007 ID - Namgaladze2014 ER - TY - JOUR AU - Nomura, M. PY - 2016 DA - 2016// TI - Fatty acid oxidation in macrophage polarization JO - Nat Immunol. VL - 17 UR - https://doi.org/10.1038/ni.3366 DO - 10.1038/ni.3366 ID - Nomura2016 ER - TY - JOUR AU - Divakaruni, A. S. PY - 2018 DA - 2018// TI - Etomoxir Inhibits Macrophage Polarization by Disrupting CoA Homeostasis JO - Cell Metab. VL - 28 UR - https://doi.org/10.1016/j.cmet.2018.06.001 DO - 10.1016/j.cmet.2018.06.001 ID - Divakaruni2018 ER - TY - JOUR AU - Li, L. PY - 2019 DA - 2019// TI - Discovery and development of small molecule modulators targeting glutamine metabolism JO - Eur J Med Chem VL - 163 UR - https://doi.org/10.1016/j.ejmech.2018.11.066 DO - 10.1016/j.ejmech.2018.11.066 ID - Li2019 ER - TY - JOUR AU - Liu, P. S. AU - Ho, P. C. PY - 2019 DA - 2019// TI - Determining macrophage polarization upon metabolic perturbation JO - Methods Mol Biol VL - 1862 UR - https://doi.org/10.1007/978-1-4939-8769-6_13 DO - 10.1007/978-1-4939-8769-6_13 ID - Liu2019 ER - TY - JOUR AU - Nelson, V. L. PY - 2018 DA - 2018// TI - PPARgamma is a nexus controlling alternative activation of macrophages via glutamine metabolism JO - Genes Dev. VL - 32 UR - https://doi.org/10.1101/gad.312355.118 DO - 10.1101/gad.312355.118 ID - Nelson2018 ER - TY - JOUR AU - Palmieri, E. M. PY - 2017 DA - 2017// TI - Pharmacologic or genetic targeting of glutamine Synthetase skews macrophages toward an M1-like phenotype and inhibits tumor metastasis JO - Cell Rep. VL - 20 UR - https://doi.org/10.1016/j.celrep.2017.07.054 DO - 10.1016/j.celrep.2017.07.054 ID - Palmieri2017 ER - TY - JOUR AU - Liu, D. PY - 2017 DA - 2017// TI - Comprehensive Proteomics Analysis Reveals Metabolic Reprogramming of Tumor-Associated Macrophages Stimulated by the Tumor Microenvironment JO - J Proteome Res. VL - 16 UR - https://doi.org/10.1021/acs.jproteome.6b00604 DO - 10.1021/acs.jproteome.6b00604 ID - Liu2017 ER - TY - JOUR AU - Penny, H. L. PY - 2016 DA - 2016// TI - Warburg metabolism in tumor-conditioned macrophages promotes metastasis in human pancreatic ductal adenocarcinoma JO - Oncoimmunology. VL - 5 UR - https://doi.org/10.1080/2162402X.2016.1191731 DO - 10.1080/2162402X.2016.1191731 ID - Penny2016 ER - TY - JOUR AU - Arts, R. J. PY - 2016 DA - 2016// TI - Transcriptional and metabolic reprogramming induce an inflammatory phenotype in non-medullary thyroid carcinoma-induced macrophages JO - Oncoimmunology. VL - 5 UR - https://doi.org/10.1080/2162402X.2016.1229725 DO - 10.1080/2162402X.2016.1229725 ID - Arts2016 ER - TY - JOUR AU - Wenes, M. PY - 2016 DA - 2016// TI - Macrophage Metabolism Controls Tumor Blood Vessel Morphogenesis and Metastasis JO - Cell Metab. VL - 24 UR - https://doi.org/10.1016/j.cmet.2016.09.008 DO - 10.1016/j.cmet.2016.09.008 ID - Wenes2016 ER - TY - JOUR AU - Xiang, W. PY - 2018 DA - 2018// TI - Monoacylglycerol lipase regulates cannabinoid receptor 2-dependent macrophage activation and cancer progression JO - Nat Commun. VL - 9 UR - https://doi.org/10.1038/s41467-018-04999-8 DO - 10.1038/s41467-018-04999-8 ID - Xiang2018 ER - TY - JOUR AU - Schumann, T. PY - 2015 DA - 2015// TI - Deregulation of PPARβ/δ target genes in tumor-associated macrophages by fatty acid ligands in the ovarian cancer microenvironment JO - Oncotarget. VL - 6 UR - https://doi.org/10.18632/oncotarget.3826 DO - 10.18632/oncotarget.3826 ID - Schumann2015 ER - TY - JOUR AU - Park, J. PY - 2015 DA - 2015// TI - M-CSF from Cancer cells induces fatty acid synthase and PPARβ/δ activation in tumor myeloid cells JO - Leading to Tumor Progression. Cell Rep. VL - 10 ID - Park2015 ER - TY - JOUR AU - Su, P. PY - 2020 DA - 2020// TI - Enhanced Lipid Accumulation and Metabolism Are Required for the Differentiation and Activation of Tumor-Associated Macrophages JO - Cancer Res. VL - 80 UR - https://doi.org/10.1158/0008-5472.CAN-19-2994 DO - 10.1158/0008-5472.CAN-19-2994 ID - Su2020 ER - TY - JOUR AU - Wu, L. PY - 2020 DA - 2020// TI - RIPK3 Orchestrates Fatty Acid Metabolism in Tumor-Associated Macrophages and Hepatocarcinogenesis JO - Cancer Immunol Res. VL - 8 UR - https://doi.org/10.1158/2326-6066.CIR-19-0261 DO - 10.1158/2326-6066.CIR-19-0261 ID - Wu2020 ER - TY - JOUR AU - Choi, J. PY - 2015 DA - 2015// TI - Glioblastoma cells induce differential glutamatergic gene expressions in human tumor-associated microglia/macrophages and monocyte-derived macrophages JO - Cancer Biol Ther. VL - 16 UR - https://doi.org/10.1080/15384047.2015.1056406 DO - 10.1080/15384047.2015.1056406 ID - Choi2015 ER - TY - STD TI - Choi SY. Cancer-generated lactic acid: a regulatory, immunosuppressive metabolite? J Pathol. 2013;230(4):350-355. ID - ref84 ER - TY - STD TI - Colegio OR. Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature. 2014;513(7519):559-563. ID - ref85 ER - TY - STD TI - Zhao Y. Bladder cancer cells re-educate TAMs through lactate shuttling in the microfluidic cancer microenvironment. Oncotarget. 2015;6(36):39196-39210. ID - ref86 ER - TY - STD TI - Cross AH. Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. J Clin Invest. 1994;93(6):2684-2690. ID - ref87 ER - TY - STD TI - Alderton WK. GW274150 and GW273629 are potent and highly selective inhibitors of inducible nitric oxide synthase in vitro and in vivo. Br J Pharmacol. 2005;145(3):301-312. ID - ref88 ER - TY - STD TI - Chatterjee PK. GW274150, a potent and highly selective inhibitor of iNOS, reduces experimental renal ischemia/reperfusion injury. Kidney Int. 2003;63(3):853-865. ID - ref89 ER - TY - STD TI - Dugo L. Effects of GW274150, a novel and selective inhibitor of iNOS activity, in acute lung inflammation. Br J Pharmacol. 2004;141(6):979-987. ID - ref90 ER - TY - STD TI - Steggerda SM. Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment. J Immunother Cancer. 2017;5(1):101. ID - ref91 ER - TY - STD TI - Zhao Q. 2-Deoxy-d-Glucose Treatment Decreases Anti-inflammatory M2 Macrophage Polarization in Mice with Tumor and Allergic Airway Inflammation. Front Immunol. 2017;8:637. ID - ref92 ER - TY - STD TI - Zhang D. 2-Deoxy-D-glucose targeting of glucose metabolism in cancer cells as a potential therapy. Cancer Lett. 2014;355(2):176-183. ID - ref93 ER - TY - STD TI - Raez LE. A phase I dose-escalation trial of 2-deoxy-D-glucose alone or combined with docetaxel in patients with advanced solid tumors. Cancer Chemother Pharmacol. 2013;71(2):523-530. ID - ref94 ER - TY - STD TI - Shi L. Roles of PFKFB3 in cancer. Signal Transduct Target Ther. 2017;2:17044. ID - ref95 ER - TY - STD TI - Clem BF. Targeting 6-phosphofructo-2-kinase (PFKFB3) as a therapeutic strategy against cancer. Mol Cancer Ther. 2013;12(8):1461-1470. ID - ref96 ER - TY - STD TI - Clem B. Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth. Mol Cancer Ther. 2008;7(1):110-120. ID - ref97 ER - TY - STD TI - Li HM. Blockage of glycolysis by targeting PFKFB3 suppresses tumor growth and metastasis in head and neck squamous cell carcinoma. J Exp Clin Cancer Res. 2017;36(1):7. . ID - ref98 ER - TY - STD TI - Zhu W. PFK15, a Small Molecule Inhibitor of PFKFB3, Induces Cell Cycle Arrest, Apoptosis and Inhibits Invasion in Gastric Cancer. PLoS One. 2016;11(9):e0163768. ID - ref99 ER - TY - STD TI - Yang W, Lu Z. Regulation and function of pyruvate kinase M2 in cancer. Cancer Lett. 2013;339(2):153-158. ID - ref100 ER - TY - STD TI - Christofk HR. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature. 2008;452(7184):230-233. ID - ref101 ER - TY - STD TI - Chen J. Shikonin and its analogs inhibit cancer cell glycolysis by targeting tumor pyruvate kinase-M2. Oncogene. 2011;30(42):4297-4306. ID - ref102 ER - TY - STD TI - Zhao X. Shikonin Inhibits Tumor Growth in Mice by Suppressing Pyruvate Kinase M2-mediated Aerobic Glycolysis. Sci Rep. 2018;8(1):14517. ID - ref103 ER - TY - STD TI - Wang Y. PKM2 inhibitor Shikonin overcomes the Cisplatin resistance in bladder Cancer by inducing Necroptosis. Int J Biol Sci. 2018;14(13):1883-1891. ID - ref104 ER - TY - STD TI - Bonnet S. A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell. 2007;11(1):37-51. ID - ref105 ER - TY - STD TI - Sun RC. Reversal of the glycolytic phenotype by dichloroacetate inhibits metastatic breast cancer cell growth in vitro and in vivo. Breast Cancer Res Treat. 2010;120(1):253-260. . ID - ref106 ER - TY - STD TI - Dunbar EM. Phase 1 trial of dichloroacetate (DCA) in adults with recurrent malignant brain tumors. Investig New Drugs. 2014;32(3):452-464. ID - ref107 ER - TY - STD TI - Matés JM. Glutaminase isoenzymes in the metabolic therapy of cancer. Biochim Biophys Acta Rev Cancer. 2018;1870(2):158-164. ID - ref108 ER - TY - STD TI - Gross MI. Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer. Mol Cancer Ther. 2014;13(4):890-901. ID - ref109 ER - TY - STD TI - Boysen G. Glutaminase inhibitor CB-839 increases radiation sensitivity of lung tumor cells and human lung tumor xenografts in mice. Int J Radiat Biol. 2019;95(4):436-442. ID - ref110 ER - TY - STD TI - Ma Z. Targeting hypoxia-inducible factor-1, for cancer treatment: recent advances in developing small-molecule inhibitors from natural compounds. Semin Cancer Biol. 2020; S1044-579X(20)30202-9. . ID - ref111 ER - TY - STD TI - Koh MY. Molecular mechanisms for the activity of PX-478, an antitumor inhibitor of the hypoxia-inducible factor-1alpha. Mol Cancer Ther. 2008;7(1):90-100. ID - ref112 ER - TY - STD TI - Welsh S. Antitumor activity and pharmacodynamic properties of PX-478, an inhibitor of hypoxia-inducible factor-1alpha. Mol Cancer Ther. 2004;3(3):233-244. ID - ref113 ER - TY - STD TI - Palayoor ST. PX-478, an inhibitor of hypoxia-inducible factor-1alpha, enhances radiosensitivity of prostate carcinoma cells. Int J Cancer. 2008;123(10):2430-2437. ID - ref114 ER - TY - STD TI - Wu J. Evaluation of a locked nucleic acid form of antisense oligo targeting HIF-1α in advanced hepatocellular carcinoma. World J Clin Oncol. 2019;10(3):149-160. ID - ref115 ER - TY - STD TI - Ben-Sahra I, Manning BD. mTORC1 signaling and the metabolic control of cell growth. Curr Opin Cell Biol. 2017;45:72-82. ID - ref116 ER - TY - STD TI - Hudes G. Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. N Engl J Med. 2007;356(22):2271-2281. ID - ref117 ER - TY - STD TI - Hess G. Phase III study to evaluate temsirolimus compared with investigator's choice therapy for the treatment of relapsed or refractory mantle cell lymphoma. J Clin Oncol. 2009;27(23):3822-3829. ID - ref118 ER - TY - STD TI - Mascarenhas L. Randomized Phase II Trial of Bevacizumab or Temsirolimus in Combination With Chemotherapy for First Relapse Rhabdomyosarcoma: A Report From the Children's Oncology Group. J Clin Oncol. 2019;37(31):2866-2874. ID - ref119 ER - TY - STD TI - Motzer RJ. Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial. Lancet Oncol. 2015 ;16(15):1473-1482. ID - ref120 ER - TY - STD TI - Fazio N. Everolimus in advanced, progressive, well-differentiated, non-functional neuroendocrine tumors: RADIANT-4 lung subgroup analysis. Cancer Sci. 2018;109(1):174-181. ID - ref121 ER - TY - STD TI - Jerusalem G. Everolimus Plus Exemestane vs Everolimus or Capecitabine Monotherapy for Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer: The BOLERO-6 Randomized Clinical Trial. JAMA Oncol. 2018;4(10):1367-1374. ID - ref122 ER - TY - STD TI - Rizzieri DA. A phase 2 clinical trial of deforolimus (AP23573, MK-8669), a novel mammalian target of rapamycin inhibitor, in patients with relapsed or refractory hematologic malignancies. Clin Cancer Res. 2008;14(9):2756-2762. ID - ref123 ER - TY - STD TI - Colombo N. Ridaforolimus as a single agent in advanced endometrial cancer: results of a single-arm, phase 2 trial. Br J Cancer. 2013;108(5):1021-1026. . ID - ref124 ER - TY - STD TI - Demetri GD. Results of an international randomized phase III trial of the mammalian target of rapamycin inhibitor ridaforolimus versus placebo to control metastatic sarcomas in patients after benefit from prior chemotherapy. J Clin Oncol. 2013;31(19):2485-2492. . ID - ref125 ER - TY - STD TI - Chawla SP. Phase II study of the mammalian target of rapamycin inhibitor ridaforolimus in patients with advanced bone and soft tissue sarcomas. J Clin Oncol. 2012;30(1):78-84. ID - ref126 ER - TY - STD TI - Wullschleger S. TOR signaling in growth and metabolism. Cell. 2006;124(3):471-484. ID - ref127 ER - TY - STD TI - Kaley TJ. Phase II trial of an AKT inhibitor (perifosine) for recurrent glioblastoma. J Neuro-Oncol. 2019;144(2):403-407. ID - ref128 ER - TY - STD TI - Hasegawa K. Phase II basket trial of perifosine monotherapy for recurrent gynecologic cancer with or without PIK3CA mutations. Investig New Drugs. 2017;35(6):800-812. ID - ref129 ER - TY - STD TI - Cho DC. Two phase 2 trials of the novel Akt inhibitor perifosine in patients with advanced renal cell carcinoma after progression on vascular endothelial growth factor-targeted therapy. Cancer. 2012;118(24):6055-6062. ID - ref130 ER - TY - STD TI - Bailey HH. Phase II study of daily oral perifosine in patients with advanced soft tissue sarcoma. Cancer. 2006;107(10):2462-2467. ID - ref131 ER - TY - STD TI - Argiris A. A phase II trial of perifosine, an oral alkylphospholipid, in recurrent or metastatic head and neck cancer. Cancer Biol Ther. 2006;5(7):766-770. ID - ref132 ER - TY - STD TI - Ernst DS. Phase II study of perifosine in previously untreated patients with metastatic melanoma. Investig New Drugs. 2005;23(6):569-575. ID - ref133 ER - TY - STD TI - Richardson PG. Perifosine plus bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma previously treated with bortezomib: results of a multicenter phase I/II trial. J Clin Oncol. 2011;29(32):4243-4249. ID - ref134 ER - TY - STD TI - Becher OJ. A phase I study of perifosine with temsirolimus for recurrent pediatric solid tumors. Pediatr Blood Cancer. 2017;64(7). https://doi.org/10.1002/pbc.26409. ID - ref135 ER - TY - JOUR AU - Guidetti, A. PY - 2014 DA - 2014// TI - Phase II study of perifosine and sorafenib dual-targeted therapy in patients with relapsed or refractory lymphoproliferative diseases JO - Clin Cancer Res VL - 20 UR - https://doi.org/10.1158/1078-0432.CCR-14-0770 DO - 10.1158/1078-0432.CCR-14-0770 ID - Guidetti2014 ER - TY - JOUR AU - Arts, R. J. PY - 2016 DA - 2016// TI - Glutaminolysis and Fumarate Accumulation Integrate Immunometabolic and Epigenetic Programs in Trained Immunity JO - Cell Metab VL - 24 UR - https://doi.org/10.1016/j.cmet.2016.10.008 DO - 10.1016/j.cmet.2016.10.008 ID - Arts2016 ER - TY - JOUR AU - Andón, F. T. PY - 2017 DA - 2017// TI - Targeting tumor associated macrophages: The new challenge for nanomedicine JO - Semin Immunol VL - 34 UR - https://doi.org/10.1016/j.smim.2017.09.004 DO - 10.1016/j.smim.2017.09.004 ID - Andón2017 ER - TY - JOUR AU - Schneemann, M. PY - 1993 DA - 1993// TI - Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes JO - J Infect Dis VL - 167 UR - https://doi.org/10.1093/infdis/167.6.1358 DO - 10.1093/infdis/167.6.1358 ID - Schneemann1993 ER -